VaIN2: Clinical Trials

1 trial for VaIN2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow VaIN2: new trials by email Literature Review of VaIN2 trials Research Report on VaIN2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
9-valent HPV vaccine - HPV Infections, Cervical Cancer
Phase 3UnknownShanghai Bovax Biotechnology Co., Ltd.12002021-05-282024-04-17

Narrower conditions

Condylomata Acuminata (1)  ·  Papillomavirus Infections (1)  ·  Uterine Cervical Neoplasms (1)  ·  Vaginal Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)

Sponsors

Shanghai Bovax Biotechnology Co., Ltd. (1)

Countries

China (1)